ENVB
Enveric Biosciences, Inc.5.24
-0.12-2.24%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
5.36MP/E (TTM)
0.00Basic EPS (TTM)
1390.68Dividend Yield
0%Recent Filings
8-K
8-K
8-K
Nasdaq delisting threat prompts split
Enveric Biosciences raised $2.2 million from warrant exercises in September 2025, boosting stockholders' equity above Nasdaq's $2.5 million threshold and addressing prior deficiency. Yet Nasdaq flagged non-compliance with the $1.00 minimum bid price on October 22, 2025, after 30 days below it, barring a grace period due to a recent reverse split. The company will implement a 1-for-12 reverse stock split effective October 28, 2025, slashing outstanding shares from 6,219,568 to about 518,297. It plans a hearing to fight delisting; success isn't assured.
8-K
Enveric raises $2.2M via warrant exercise
Enveric Biosciences secured $2.2 million in gross proceeds on September 18, 2025, by inducing holders to exercise existing Series A and B warrants for 2,424,998 shares at a reduced $0.915 per share, down from $3.00. In exchange, the company issued new Series C warrants, exercisable for five years post-stockholder approval, and Series D warrants for 18 months, both at $0.915. Funds will fuel product development and working capital, yet stockholder approval remains a key hurdle.
8-K
Enveric relocates to Cambridge hub
Enveric Biosciences relocated its corporate headquarters to Cambridge, Massachusetts, effective September 2, 2025, tapping into the Greater Boston biotech hub's talent and investor ecosystem. This move bolsters collaborations and visibility as the company advances EB-003, a novel neuroplastogen targeting psychiatric disorders, toward first-in-human trials in 2026. Relocation fuels growth. Yet risks like clinical delays loom large.
AIBT
Aibotics Inc.
0.00+0.00
CBIO
Crescent Biopharma, Inc.
12.92-0.29
CNBX
CNBX Pharmaceuticals Inc.
0.00+0.00
CPMV
Mosaic ImmunoEngineering Inc.
0.40+0.00
CYBN
Cybin Inc.
6.66+0.00
DRUG
Bright Minds Biosciences Inc.
93.99+8.32
ELVN
Enliven Therapeutics, Inc.
16.91-0.26
ENDV
Endonovo Therapeutics, Inc.
0.00+0.00
LBRX
LB Pharmaceuticals Inc
19.82-0.04
PBM
Psyence Biomedical Ltd.
1.53+0.05